Literature DB >> 867331

Metabolic response to intravenous salbutamol therapy in acute asthma.

T R Tickner, D G Cramp, A Y Foo, A J Johnson, S M Bateman, J Pidgeon, S G Spiro, S W Clarke, M R Wills.   

Abstract

In patients suffering from an acute attack of asthma the effects of salbutamol infusion (10 microng/min) on their plasma concentrations of non-esterified fatty acids (NEFA), triglyceride, insulin, and glucose were compared with those in a group of asthmatics not requiring infusion. Salbutamol was found significantly to increase the plasma concentrations of glucose and insulin while having little effect on NEFA or triglyceride. However, NEFA concentrations were found to be significantly increased in patients with an acute attack of asthma at the time of their admission to hospital. This increase is attributed to the stress of the asthmatic attack itself.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 867331      PMCID: PMC470564          DOI: 10.1136/thx.32.2.182

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  4 in total

1.  Metabolic responses to selective beta-adrenergic stimulation in man.

Authors:  R Goldberg; M van As; B I Joffe; L Krut; I Bersohn; H C Seftel
Journal:  Postgrad Med J       Date:  1975-02       Impact factor: 2.401

Review 2.  Metabolic response during impending myocardial infarction. II. Clinical implications.

Authors:  M F Oliver
Journal:  Circulation       Date:  1972-02       Impact factor: 29.690

3.  Free fatty acid estimation by a semi-automated fluorimetric method.

Authors:  M Carruthers; D A Young
Journal:  Clin Chim Acta       Date:  1973-12-27       Impact factor: 3.786

4.  The fluorometric assay of triglyceride by a semiautomated method.

Authors:  D G Cramp; G Robertson
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

  4 in total
  6 in total

1.  The metabolic effects of inhaled salbutamol.

Authors:  S M Bateman; J Pidgeon; S G Spiro; A J Johnson
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

2.  The metabolic response to the activation of the beta-adrenergic receptor by salbutamol is amplified by acylated ghrelin.

Authors:  D H St-Pierre; A Benso; E Gramaglia; F Prodam; B Lucatello; V Ramella-Gigliardi; I Olivetti; M Tomelini; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

3.  Metabolic effects of intravenous salbutamol in the course of acute severe asthma.

Authors:  S G Nogrady; J P Hartley; A Seaton
Journal:  Thorax       Date:  1977-10       Impact factor: 9.139

4.  The metabolic actions of intravenous salbutamol and aminophylline singly and in combination.

Authors:  C R Jenkins; G E Marlin
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

5.  Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.

Authors:  R Canepa-Anson; J R Dawson; P Kuan; P A Poole-Wilson; G C Sutton; B Cockrill; S R Reuben
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

6.  Metabolic and cardiovascular side effects of the beta 2-adrenoceptor agonists salbutamol and rimiterol.

Authors:  P J Phillips; A E Vedig; P L Jones; M G Chapman; M Collins; J B Edwards; T C Smeaton; B M Duncan
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.